|
|
 |
|
Viewing report
|
|
|
|
Thought Leader Insight & Analysis Report: Anticoagulants Q2 2010
Medpredict, May 2010, Pages: 117
This Cardiovascular Thought Leader Panel reviews the most important anticoagulant data presented at ACC 2010 with six international Thought Leaders who have a stake in anticoagulation therapy. The discussions took place in late April/early May 2010. This Panel focuses on the use of antithrombotics and antiplatelets in the prevention of cerebrovascular events associated with acute coronary syndrome (ACS) or secondary prevention of atrial fibrillation (SPAF). Picking up where they left off in our last report, this Panel opines on competitive strengths and weaknesses of marketed products and experimental therapeutics with high likelihood of being commercialized. Panelists differentiate each drug based on clinical trial design, anticoagulant efficacy, increased bleeding risk, convenience, associated therapeutic limitations, costs and genetic screening/diagnostics.
This report provides essential strategic insight for key stakeholders in the anticoagulants market at a significant value versus customized primary research
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
